News

Article

FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx